Studies in subjects with positive postprandial Clinistix test. 3. Special studies and follow-up of cases with borderline glucose tolerance.
D000284:Administration, Oral; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis; D003922:Diabetes Mellitus, Type 1; D004035:Diet Therapy; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D007202:Indicators and Reagents; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008722:Methods; D008875:Middle Aged; D005082:Physical Exertion; D010919:Placebos; D011236:Prediabetic State / Q000628:therapy; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007202:Indicators and Reagents; D007328:Insulin; D010919:Placebos; D014044:Tolbutamide